Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820451 · ClinicalTrials.gov registry record
Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
A clinical trial, sponsored by Abiomed.
- Completed
- Registry status
- 312
- Enrollment target
NCT05820451: Completed study, sponsored by Abiomed.
NCT05820451 is a clinical trial that has completed, run by Abiomed. The registered enrollment target is 312 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820451 has completed, sponsored by Abiomed.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
Study Summary
The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
Primary Outcome
Rate of heiarchical composite of stroke, transient ischemic attack (TIA), left ventricular (LV) thrombus
Interventions
- DEVICE Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
- DEVICE Impella RP with Sodium Bicarbonate used as purge solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2022-12-15 |
| Est. Completion | 2024-02-22 |
What the finished NCT05820451 record still lists
NCT05820451 is an observational study that tracks outcomes without assigning an intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution is the first listed.
NCT05820451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05820451 about?
NCT05820451 is a clinical study titled "Impella Real-World Surveillance of Patients Using Sodium Bicarbonate". The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
What is the current status of trial NCT05820451?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2022-12-15. Estimated completion is 2024-02-22.
What interventions are being tested in trial NCT05820451?
The interventions under investigation include: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution (DEVICE), Impella RP with Sodium Bicarbonate used as purge solution (DEVICE).
Who is sponsoring clinical trial NCT05820451?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI